Enteral Nutrition Market Scope And Analysis

Report Code : TIPRE00004763
Category : Life Sciences

Status : Published
No. of Pages : 233

Buy Now

Enteral Nutrition Market Analysis, Trends, and Scope 2023 to 2030

Buy Now

Enteral Nutrition Market Report Scope

Report Attribute	Details
Market size in 2022	US$ 8.28 Billion
Market Size by 2030	US$ 13.2 Billion
Global CAGR (2022 - 2030)	6.0%
Historical Data	2020-2021
Forecast period	2023-2030
Segments Covered	By Product Type General and Disease Specific By Application Gastrointestinal Disorders Metabolic/Inborn Errors of Metabolism Food Allergy Renal Disease Liver Disease Oncology Neurology By Age Group Adult and Pediatric By Distribution Channel Hospital Pharmacies Retail Stores E-Commerce
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Nestl Danone S A Abbott Laboratories FrieslandCampina Fresenius SE and Co KGaA B Braun SE Dr Sch r AG Arla Food Reckitt Benckiser

Recent Developments:

Inorganic and organic strategies such as mergers and acquisitions are highly adopted by companies in the enteral nutrition market. A few recent key market developments are listed below:

In January 2023, Nutricia launched Fortimel PlantBased Energy, its first plant-based, ready-to-drink oral nutritional supplement. The product is specifically formulated to fulfill the nutritional needs of malnourished populations or people at risk of malnutrition due to certain illness. Following the launch of Fortimel, the company plans to build on Danone's (parent company) expertise in plant nutrition to expand its Fortimel portfolio. The new product is available in the Netherlands, Denmark, Norway, Spain, Finland, and the Czech Republic.
In June 2022, Nestlé Health Science acquired The Better Health Company (TBHC), the parent company of GO Healthy and Egmont, from CDH Investments and TBHC founding shareholders. Through this transaction, Nestlé Health Science would acquire TBHC in its entirety. This includes GO Healthy, a leading supplement brand of New Zealand; New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins, minerals, and supplements; and the Manuka honey brand, Egmont.
In May 2022, Nestlé Health Science acquired Puravida, a premium Brazilian nutrition and health lifestyle brand. With this acquisition, NHSc intends to expand its consumer health portfolio in Brazil. Puravida's mix of products complements Nestlé Health Science’s portfolio, which offers oral nutritional supplements, protein powders, and ready-to-drink nutritional beverages in Brazil.
In November 2021, Abbott Launched Similac 360 Total Care to support the immune system, digestive health, and brain development in babies. Similac 360 Total Care is the first and only infant formula in the US with a blend of five different HMOs, which are only found together in breast milk.